STOCK TITAN

Airsculpt Technologies, Inc. - AIRS STOCK NEWS

Welcome to our dedicated page for Airsculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on Airsculpt Technologies stock.

Overview

AirSculpt Technologies, Inc. is a national provider of advanced body contouring procedures, renowned for its innovative and minimally invasive procedures. Operating under the Elite Body Sculpture brand, the company specializes in custom fat removal techniques that target unwanted fat deposits while enhancing skin tightness. Leveraging a proprietary AirSculpt method, AirSculpt Technologies delivers a premium consumer experience by minimizing trauma, reducing bruising, and promoting rapid healing.

Innovative Technology and Procedure

At the heart of AirSculpt’s offering is its state-of-the-art technology which combines helium gas with radiofrequency energy to create a unique plasma. This specialized plasma is precisely controlled to remove fat deposits and tighten the skin in targeted body areas. The process is designed to maintain the natural aesthetic contours of the body while offering a custom and personalized treatment plan.

The company’s advanced procedure is characterized by:

  • Proprietary Technology: The patented AirSculpt method ensures that fat removal is conducted in a manner that significantly reduces healing time relative to traditional surgical approaches.
  • Minimally Invasive Treatment: By minimizing tissue trauma, the procedure supports quicker recovery and less discomfort, meeting the needs of today's discerning consumers focused on comfort and efficiency.
  • Enhanced Techniques: An additional offering, known as AirSculpt+, integrates a skin tightening effect, using innovative energy modalities to bolster the cosmetic benefits of the initial procedure.

Market Presence and Operational Excellence

AirSculpt Technologies has established a robust national footprint by strategically situating its centers in upscale and accessible locations. These centers are meticulously designed, often incorporating multiple operating rooms that facilitate concurrent treatments, thereby maximizing operational efficiency. By expanding its presence in key markets across North America and extending its reach to the U.K., the company has tailored its operational model to engage a wide range of consumers seeking non-surgical body enhancement.

The company’s approach is built on the following pillars:

  • Consumer-Centric Experience: Each clinic is designed to provide a premium and personalized service, ensuring that every patient receives customized treatment plans.
  • Strategic Location Selection: The centers are often located in high-traffic, upscale shopping areas, which align with the consumer demographic interested in aesthetic treatments.
  • Operational Efficiency: With carefully optimized layouts and state-of-the-art facilities, AirSculpt is able to perform multiple procedures simultaneously, enhancing its service capacity and reducing waiting times for patients.

Brand Positioning and Consumer Benefits

Under the Elite Body Sculpture banner, AirSculpt Technologies positions itself as a sophisticated choice for patients prioritizing both aesthetic improvement and a quality service experience. The company’s procedures are particularly noted for:

  • Precision: Highly precise removal of fat in targeted areas, which results in natural-looking body contours.
  • Comfort: Minimally invasive techniques that ensure a significant reduction in post-procedure recovery time compared to traditional surgeries.
  • Customization: Personalized treatment plans that effectively address individual patient needs and desired outcomes.

This approach not only addresses the physical aesthetic concerns of its clientele but also contributes to enhanced self-confidence and emotional well-being, which are key drivers in the broader cosmetic and aesthetic market.

Competitive Landscape and Differentiation

In an industry dotted with providers of cosmetic and body contouring solutions, AirSculpt distinguishes itself through a combination of proprietary technology and a focus on the premium consumer experience. While other companies may offer similar aesthetic procedures, AirSculpt’s strategy includes:

  • Patented Methods: The exclusive AirSculpt technique sets a high benchmark in terms of treatment efficiency and outcome quality.
  • Operational Rigor: The emphasis on a controlled clinical environment with modern surgical suites enhances both patient safety and process reliability.
  • Brand Consistency: Under the consistent Elite Body Sculpture branding, the company has built a reputation for quality and precision in body contouring, becoming a notable name among cosmetic procedure providers.

Industry-Specific Expertise and Business Model Nuances

The business model of AirSculpt Technologies incorporates several layers of expertise that resonate with industry specialists and investors alike. On one hand, the company has mastered the clinical aspects of fat removal through detailed procedural protocols. On the other, it leverages an asset-light operational strategy by focusing on premium, well-located centers that facilitate high patient throughput with minimized overheads.

This dual focus on technical process integrity and operational efficiency has allowed AirSculpt to maintain a strong competitive edge despite the pressures of a crowded market. Furthermore, its ability to innovate through adjunct procedures like AirSculpt+ and stay ahead of emerging trends in aesthetic medicine exemplifies its commitment to continuous enhancement and precision technology.

Expertise, Experience, and Trustworthiness

The comprehensive approach that defines AirSculpt Technologies is a testament to its deep industry expertise. With a seasoned leadership team experienced in both aesthetics and operational strategy, the company has demonstrated an unwavering commitment to quality and consistent patient outcomes. Detailed attention is given to every aspect of the treatment process, from initial consultation to post-procedure recovery, ensuring that the clinical experience aligns with the brand's premium promise.

Moreover, the extensive track record of successfully completed procedures, validated by thousands of cases performed over the years, reinforces the reliability and effectiveness of its methods. This extensive experience, combined with rigorous adherence to safety protocols and continuous technology updates, makes AirSculpt a trusted name in the field of aesthetic treatments.

Conclusion

In summary, AirSculpt Technologies, Inc. stands out as a sophisticated operator in the body contouring domain. By integrating advanced technological innovations with a premium, consumer-focused business model, the company not only offers a high-quality, minimally invasive treatment alternative but also sets benchmarks in operational efficiency and clinical precision. For investors and market researchers, understanding the intricate balance between technological prowess and strategic market positioning that AirSculpt demonstrates provides a valuable insight into its operational excellence and sector significance.

Rhea-AI Summary

AirSculpt Technologies (NASDAQ:AIRS) reported challenging fourth quarter and full year 2024 results, showing significant declines across key metrics. Q4 revenue dropped 17.7% to $39.2 million, with case volume declining 16.7% to 3,064 cases. The company posted a Q4 net loss of $5.0 million.

For full year 2024, revenue decreased 7.9% to $180.4 million, with case volume falling 6.0% to 14,036. Net loss widened to $8.3 million from $4.5 million in 2023, while Adjusted EBITDA declined to $20.7 million from $43.2 million.

The company has implemented a cost reduction program targeting $3 million in annual savings and has paused new center openings. With $8.2 million in cash and operating cash flow of $11.4 million for 2024, AirSculpt has secured additional covenant relief from lenders to support its transformation efforts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.72%
Tags
-
Rhea-AI Summary

AirSculpt Technologies (NASDAQ: AIRS), a premium body contouring procedures provider, has scheduled its fourth quarter 2024 financial results announcement for Friday, March 14, 2025, before market open.

The company will host a conference call at 8:30 a.m. Eastern Time on the same day. Investors can access the call through toll-free domestic (1-877-407-9716) or international (1-201-493-6779) numbers using conference ID 13751643. A live webcast will be available through the investor relations section of AirSculpt's website, with a replay accessible for approximately 90 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.24%
Tags
conferences earnings
-
Rhea-AI Summary

AirSculpt Technologies (NASDAQ: AIRS) has updated its fiscal year 2024 guidance, lowering expectations from previous projections. The company now anticipates revenues of approximately $180.0 million, down from the previous guidance of $183-189 million, and Adjusted EBITDA of approximately $20.5 million, reduced from the previous $23-28 million range.

New CEO Yogi Jashnani, who recently started his position, outlined plans to stabilize revenue and return to growth by implementing business process changes and enhancing technology usage. The company, which has performed over 70,000 procedures across 32 global centers, aims to leverage its proprietary technology and asset-light business model for long-term profitable growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.9%
Tags
Rhea-AI Summary

AirSculpt Technologies (NASDAQ: AIRS), a premium body contouring procedures provider, has announced its participation in the upcoming ICR Conference 2025 at The Grande Lakes Orlando in Florida. The event will take place from January 13-14, 2025.

CEO Yogi Jashnani and CFO Dennis Dean will conduct investor meetings and deliver a presentation on January 14, 2025, at 10:00 a.m. EST. The presentation will be accessible via live webcast on the company's investor relations website, with the recording remaining available for 90 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.17%
Tags
none
-
Rhea-AI Summary

AirSculpt Technologies (NASDAQ:AIRS) has appointed Yogi Jashnani as Chief Executive Officer and Board member, effective January 7, 2025. Jashnani succeeds Interim CEO Dennis Dean, who will continue as Chief Financial Officer. With over two decades of experience, Jashnani joins from Sky Zone where he served as Chief Revenue Officer.

Previously, as Chief Commercial Officer at Ideal Image, Jashnani drove growth through loyalty programs and new services. His experience includes executive roles at Advance Auto Parts, where he doubled eCommerce revenue, and Capital One Financial Services. The appointment aims to capitalize on AirSculpt's market position in premium body contouring procedures.

Jashnani's priorities will focus on accelerating same-center sales growth, enhancing operational efficiencies, and maximizing the potential of the AirSculpt method.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags
none
-
Rhea-AI Summary

AirSculpt Technologies (NASDAQ: AIRS) has announced the opening of its new body contouring center in White Plains, NY, marking its 32nd location. The new facility features three operating rooms for simultaneous procedures and offers the AirSculpt+ skin tightening procedure. This expansion represents the company's second location in New York, responding to growing market demand. The AirSculpt+ procedure combines fat removal with Renuvion® technology, using helium gas and radiofrequency energy for skin tightening. Since 2012, over 60,000 AirSculpt procedures have been performed across their locations in the U.S., Canada, and the United Kingdom.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.32%
Tags
none
Rhea-AI Summary

AirSculpt Technologies (NASDAQ:AIRS) reported Q3 2024 results with revenue of $42.5 million, representing a 9.1% decline from Q3 2023. The company posted a net loss of $6.0 million and Adjusted EBITDA of $4.7 million. Case volume decreased 4.3% to 3,277 cases. Despite challenges in the consumer environment, the company opened four new centers during the quarter. For the first nine months of 2024, revenue declined 4.8% to $141.2 million. The company affirmed its 2024 guidance with revenue expected between $183-189 million and Adjusted EBITDA between $23-28 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.72%
Tags
-
Rhea-AI Summary

AirSculpt® Technologies, Inc. (NASDAQ: AIRS), a leader in premium body contouring procedures, has opened a new center in Birmingham, MI, increasing its total locations to 31. The center, located at 555 S. Old Woodward Avenue Suite 500, features two operating rooms for concurrent procedures and offers the popular AirSculpt®+ skin tightening procedure.

Dennis Dean, Interim CEO, expressed excitement about introducing AirSculpt's exclusive technology to Birmingham. The clinic is situated on the main strip, surrounded by upscale retail shops. AirSculpt®+ combines AirSculpt® fat removal with Renuvion® treatment, using helium gas and radiofrequency energy to tighten skin and improve laxity.

Since 2012, over 60,000 AirSculpt® cases have been performed across the company's locations in the U.S., Canada, and the United Kingdom.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.31%
Tags
none
-
Rhea-AI Summary

AirSculpt® Technologies, Inc. (NASDAQ: AIRS), a leading provider of premium body contouring procedures, has announced the opening of a new center in Deerfield, IL. This expansion brings the company's total location count to 30. The new center, located at 720 Waukegan Rd Suite 200, features three operating rooms and offers the popular AirSculpt®+ skin tightening procedure.

Dennis Dean, Interim CEO, expressed excitement about bringing AirSculpt's proprietary technology to Deerfield, citing strong demand in their existing Chicago clinic. The AirSculpt®+ procedure combines AirSculpt® fat removal with Renuvion® skin tightening technology, offering patients a comprehensive body contouring solution.

Since 2012, AirSculpt® has performed over 60,000 cases across its locations in the U.S., Canada, and the United Kingdom. The company continues to expand its presence to meet growing market demand for premium body contouring services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.34%
Tags
none
Rhea-AI Summary

AirSculpt® Technologies, Inc. (NASDAQ: AIRS), a leader in premium body contouring, has opened its 29th center in Columbus, OH. The new facility, located at 4100 Regent St Suite 4-H in Easton Town Center, features two operating rooms for concurrent procedures. The center also offers the popular AirSculpt®+ skin tightening procedure, which combines AirSculpt® fat removal with Renuvion® technology for improved skin laxity. This minimally invasive treatment uses helium gas and radiofrequency energy to create a plasma that corrects sagging skin and restores a youthful appearance. Since 2012, AirSculpt® has performed over 60,000 cases across its locations in the U.S., Canada, and the United Kingdom.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.74%
Tags
none

FAQ

What is the current stock price of Airsculpt Technologies (AIRS)?

The current stock price of Airsculpt Technologies (AIRS) is $2.06 as of April 9, 2025.

What is the market cap of Airsculpt Technologies (AIRS)?

The market cap of Airsculpt Technologies (AIRS) is approximately 103.1M.

What is AirSculpt Technologies, Inc.?

AirSculpt Technologies, Inc. is a national provider of advanced body contouring procedures, offering minimally invasive treatments under its Elite Body Sculpture brand.

How does the AirSculpt procedure work?

The procedure utilizes a unique, patented technology that combines helium gas with radiofrequency energy to create plasma for precise fat removal and skin tightening.

What differentiates AirSculpt from other body contouring providers?

AirSculpt stands out due to its proprietary method, premium clinic environments, and a focus on precision and rapid recovery with minimal tissue trauma.

How many treatment centers does AirSculpt operate?

AirSculpt operates multiple centers in North America and has an established presence in the U.K., strategically located in upscale areas to better serve its clientele.

What is AirSculpt+?

AirSculpt+ is an additive procedure that builds on the primary fat reduction process by offering an additional skin tightening effect using advanced energy modalities.

Who typically seeks treatment at AirSculpt centers?

The treatment is designed for consumers looking for tailored body contouring solutions that offer precise fat removal along with skin tightening, resulting in enhanced natural aesthetics and fast recovery.
Airsculpt Technologies, Inc.

Nasdaq:AIRS

AIRS Rankings

AIRS Stock Data

103.09M
12.62M
26.71%
73.13%
5.33%
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
Link
United States
MIAMI BEACH